Welcome to our dedicated page for Diversified Healthcare Tr news (Ticker: DHC), a resource for investors and traders seeking the latest updates and insights on Diversified Healthcare Tr stock.
Diversified Healthcare Trust (Nasdaq: DHC) is a Maryland real estate investment trust focused on owning high-quality healthcare properties across the United States. Its portfolio includes senior living communities, medical office buildings and life science properties, and the trust is managed by The RMR Group, an alternative asset manager specializing in commercial real estate. This news page aggregates company announcements and market updates related to DHC’s operations, portfolio and capital structure.
Readers can find press releases on quarterly and annual financial results, including summaries of performance for the senior housing operating portfolio (SHOP) and the office and life science properties. DHC regularly issues updates on its capital recycling program, such as the sale of non-core properties and the use of proceeds to repay or refinance debt, including senior secured notes. News items also cover changes in the operator base for DHC’s senior living communities, including the transition of management agreements from AlerisLife Inc. to multiple senior living operators.
In addition, this feed includes announcements of regular quarterly cash distributions on DHC’s common shares, along with explanations of the factors the Board of Trustees considers when setting distribution rates. Coverage may also reference DHC’s participation in joint ventures, such as its minority equity interest in a venture that owns Vertex Pharmaceuticals Incorporated’s headquarters in the Boston Seaport district, as disclosed by The RMR Group.
Investors and observers who follow DHC’s news can use this page to monitor developments in its healthcare real estate portfolio, debt financing activities, operator transitions and distribution declarations. For those analyzing DHC stock, the news stream provides context on how the trust manages its properties, capital and relationships with operators and tenants over time.
Diversified Healthcare Trust (Nasdaq: DHC) will release its Q4 2025 financial results after Nasdaq closes on Monday, February 23, 2026. A conference call to discuss results is scheduled for Tuesday, February 24, 2026 at 10:00 a.m. ET, hosted by CEO Christopher Bilotto, CFO Matthew Brown and VP Anthony Paula.
Dial-in numbers: (877) 329-4297 (U.S./Canada) and (412) 317-5435 (international); no pass code is required. Callers are advised to dial ~15 minutes early. A replay is available through 11:59 p.m. ET on March 3, 2026 at (855) 669-9658 with pass code 7932578. A live listen-only webcast and archived replay will be available at the company website www.dhcreit.com.
Diversified Healthcare Trust (Nasdaq: DHC) announced final 2025 dividend tax characterizations for DHC common shares. The company reported four quarterly distributions of $0.0100 per share (record/payment: 01/27/25–02/20/25; 04/22/25–05/15/25; 07/21/25–08/14/25; 10/27/25–11/13/25) for a total of $0.0400 per share in 2025.
All amounts are allocated as return of capital ($0.0400 total); ordinary income, qualified dividends, Section 199A, capital gains and Section 1250 amounts are reported as $0.00. The CUSIP is 25525P107. Shareholders should use IRS Form 1099-DIV for tax reporting and may consult Form(s) 8937 on the company website for tax-basis effects.
Diversified Healthcare Trust (Nasdaq: DHC) announced a regular quarterly cash distribution on its common shares of $0.01 per share (annualized $0.04 per share). The distribution is payable to shareholders of record as of the close of business on January 26, 2026 and will be distributed on or about February 19, 2026.
Diversified Healthcare Trust (Nasdaq: DHC) provided a business update on January 5, 2026 highlighting its 2025 capital recycling, debt repayment and operator transitions.
DHC completed sale of 69 non-core properties for ≈$605 million in 2025, including 37 properties for ≈$250 million in Q4 2025, and is under agreement to sell 13 SHOP communities for ≈$26 million expected to close in Q1 2026. DHC fully repaid its 2026 zero coupon senior secured notes on Dec 29, 2025, freeing 45 collateral properties (~$850 million gross book value) and leaving no debt maturing until 2028. DHC also completed transition of 116 SHOP communities from AlerisLife to new operators and reports full availability under its revolving credit facility.
Diversified Healthcare Trust (Nasdaq: DHC) announced its financial results for the quarter ended September 30, 2025 and directed investors to the Quarterly Reports section of its website for the full filings and multimedia release.
The company will host a conference call to discuss third quarter 2025 results on Tuesday, November 4, 2025 at 10:00 a.m. ET; domestic dial-in is (877) 329-4297 and international dial-in is (412) 317-5435 with no pass code required. A replay will be available for one week at (877) 344-7529 using pass code 3384068. A live listen-only webcast and archived replay are available at www.dhcreit.com.
Diversified Healthcare Trust (Nasdaq: DHC) announced a regular quarterly cash distribution of $0.01 per common share (annualized $0.04 per share).
The distribution is payable to shareholders of record at the close of business on October 27, 2025 and will be distributed on or about November 13, 2025.
Diversified Healthcare Trust (Nasdaq: DHC) announced that 116 SHOP management agreements formerly managed by AlerisLife are being transferred to seven operators: Sinceri (38 communities, 7,299 units), Discovery (44, 5,338), Tutera (19, 2,051), Stellar (6, 1,032), WellQuest (5, 796), Phoenix (3, 366) and Ciel (1, 308).
Transitions began in mid-September and are expected to be completed by year-end. AlerisLife is selling its 17 owned communities and plans a full wind-down in H1 2026. DHC expects $25–$40 million net proceeds for its 34% interest, to be used to reduce leverage and reinvest in SHOP. Eureka Capital Markets serves as financial advisor and DHC posted an investor presentation with further details.
Diversified Healthcare Trust (Nasdaq: DHC) will release its third quarter 2025 financial results after Nasdaq closes on Monday, November 3, 2025.
The company will host a conference call on Tuesday, November 4, 2025 at 10:00 a.m. Eastern Time with CEO Christopher Bilotto, CFO Matthew Brown and VP Anthony Paula. Dial-in numbers: (877) 329-4297 (US/Canada) or (412) 317-5435 (international). Callers should dial about 15 minutes before start; no pass code is required.
A live listen-only webcast will be available at www.dhcreit.com, with the archived webcast posted after the call. A replay of the call is available through 11:59 p.m. ET on November 11, 2025 at (877) 344-7529 using pass code 3384068.
Diversified Healthcare Trust (Nasdaq: DHC) has priced $375 million of senior secured notes due October 2030 with a 7.25% interest rate. The offering is expected to close on September 26, 2025.
The notes will be guaranteed by DHC subsidiaries owning 36 U.S. properties and will be secured by first-priority liens on the equity interests in these subsidiaries. DHC plans to use the proceeds to partially redeem approximately $307 million of its existing 2026 Notes, with the remainder to be redeemed in Q4 2025 using asset sales proceeds, cash on hand, and credit facility funds.
Diversified Healthcare Trust (Nasdaq: DHC) has announced agreements to transition the management of 116 senior living communities from AlerisLife's Five Star Senior Living division to seven different operators. The transition will occur in phases starting September 2025 and complete by year-end.
AlerisLife is selling all its assets, including 17 owned communities, and will wind down operations by first half of 2026. DHC, which owns a 34% stake in AlerisLife, expects to receive $25-40 million in net proceeds from this wind-down, which it plans to use for reducing leverage and reinvesting in its SHOP segment.
The transaction, resulting from a competitive bidding process involving over 300 potential buyers, aims to improve SHOP communities' operating performance, strengthen DHC's balance sheet, and create operational efficiencies through geographic market concentration.